共 43 条
[1]
DeVita, Hellman, Rosenberg, Cancer, Principles and Practice of Oncology, (1985)
[2]
Diasio, Harris, Clinical pharmacology of 5-fluorouracil, Clin. Pharmacokin., 16, pp. 215-237, (1989)
[3]
Christophidis, Vajda, Lucas, Drummer, Moon, Louis, Fluorouracil therapy in patients a pharmacokinetic comparison of various rates and routes of administration, Clinical Pharmacokinetics, 3, pp. 330-336, (1978)
[4]
Buur, Bundgaard, Prodrugs of 5-fluorouracil. I. Hydrolysis kinetics and physicochemical properties of various N-acyl derivatives of 5-fluorouracil, Int. J. Pharm., 21, pp. 349-364, (1984)
[5]
Buur, Bundgaard, Prodrugs of 5-fluorouracil. II. Hydrolysis kinetics, bioactivation, solubility and lipophilicity of N-alkoxycarbonyl derivatives of 5-fluorouracil, Arch. Pharm. Chemi., Sci. Ed., 12, pp. 37-44, (1984)
[6]
Buur, Bundgaard, Prodrugs of 5-fluorouracil. III. Hydrolysis kinetics in aqueous solution and biological media, lipophilicity and solubility of various 1-carbamoyl derivatives of 5-fluorouracil, Int. J. Pharm., 23, pp. 209-222, (1985)
[7]
Buur, Bundgaard, Falch, Prodrugs of 5-fluorouracil. IV. Hydrolysis kinetics, bioactivation and physicochemical properties of various N-acyloxymethyl derivatives of 5-fluorouracil, Int. J. Pharm., 24, pp. 43-60, (1985)
[8]
Buur, Bundgaard, Prodrugs of 5-fluorouracil. V. 1-Alkoxycarbonyl derivatives as potential prodrug forms for improved rectal or oral delivery of 5-fluoroacil, J. Pharm. Sci., 75, pp. 522-527, (1986)
[9]
Buur, Bundgaard, Prodrugs of 5-fluorouracil. VI. Hydrolysis kinetics and bioactivation of 3-nicotinoyl-5-fluorouracil and various 1-substituted derivatives of 3-benzoyl-5-fluorouracil, Arch. Pharm. Chemi, Sci. Ed., 14, pp. 99-112, (1986)
[10]
Buur, Bundgaard, Falch, Prodrugs of 5-fluorouracil. VII. Hydrolysis kinetics and physicochemical properties of N-ethoxy- and N-phenoxycarbonyloxymethyl derivatives of 5-fluorouracil, Acta Pharm. Suec., 23, pp. 205-216, (1986)